FR2613617B1 - Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine - Google Patents

Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine

Info

Publication number
FR2613617B1
FR2613617B1 FR878705027A FR8705027A FR2613617B1 FR 2613617 B1 FR2613617 B1 FR 2613617B1 FR 878705027 A FR878705027 A FR 878705027A FR 8705027 A FR8705027 A FR 8705027A FR 2613617 B1 FR2613617 B1 FR 2613617B1
Authority
FR
France
Prior art keywords
diethoxycarbonyl
dihydropyridine
therapy
dimethyl
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR878705027A
Other languages
English (en)
Other versions
FR2613617A1 (fr
Inventor
Gunar Yanovich Dubur
Egils Arvidovich Biseniex
Yan Rikhardovich Uldrikis
Evgeny Vasilievich Ivanov
Tatyana Vasilievna Ponomareva
Gennady Nikolaevich Merkushev
Jury Osipovi Yakubovsky-Lipsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST ORGANICHESKOGO SINTEZA AK
LE I RADIATSION
Original Assignee
INST ORGANICHESKOGO SINTEZA AK
LE I RADIATSION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST ORGANICHESKOGO SINTEZA AK, LE I RADIATSION filed Critical INST ORGANICHESKOGO SINTEZA AK
Publication of FR2613617A1 publication Critical patent/FR2613617A1/fr
Application granted granted Critical
Publication of FR2613617B1 publication Critical patent/FR2613617B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR878705027A 1986-09-30 1987-04-09 Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine Expired - Fee Related FR2613617B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863633315 DE3633315A1 (de) 1986-09-30 1986-09-30 Mittel zur prophylaxe und behandlung von hautverbrennungen durch strahlen

Publications (2)

Publication Number Publication Date
FR2613617A1 FR2613617A1 (fr) 1988-10-14
FR2613617B1 true FR2613617B1 (fr) 1991-09-06

Family

ID=6310753

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878705027A Expired - Fee Related FR2613617B1 (fr) 1986-09-30 1987-04-09 Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine

Country Status (4)

Country Link
US (1) US4769382A (fr)
DE (1) DE3633315A1 (fr)
FR (1) FR2613617B1 (fr)
GB (1) GB2203647B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2231328A (en) * 1989-05-04 1990-11-14 Inst Organicheskogo Sinteza Ak 2,6-dimethyl-1,4-dihydrophyridine-3,5-carboxylic acid adamantyl esters
US5470860A (en) * 1991-12-13 1995-11-28 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridines for use in the treatment of dermatoses
US5523077A (en) * 1992-02-06 1996-06-04 Yale University Composition and method for whitening skin
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US20020034524A1 (en) * 2000-06-19 2002-03-21 Poret Jacques Louis Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces
CA2602612A1 (fr) * 2005-04-04 2006-10-12 Bioartificial Gel Technologies Inc. Prevention et traitement d'une radiodermite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE873440C (de) * 1951-04-12 1953-04-13 Hans Dr Med Koehnle Verfahren zur Herstellung einer Schutzsalbe, insbesondere fuer mit Roentgenstrahlen arbeitende AErzte
GB1426499A (en) * 1973-10-02 1976-02-25 I Organischeskogo Sinteza Akad Pharmaceutical composition for treating liver diseases
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
US4548973A (en) * 1984-08-27 1985-10-22 Olin Corporation Selected 2,2,6,6-tetramethyl-4-piperidinyl derivatives and their use as light stabilizers

Also Published As

Publication number Publication date
GB2203647B (en) 1990-11-14
DE3633315A1 (de) 1988-04-21
GB2203647A (en) 1988-10-26
GB8707920D0 (en) 1987-05-07
DE3633315C2 (fr) 1990-01-25
FR2613617A1 (fr) 1988-10-14
US4769382A (en) 1988-09-06

Similar Documents

Publication Publication Date Title
ATE363283T1 (de) Terfenadin-carboxylat und die behandlung von hautreizung
IE790756L (en) Cerebral therapeutic agent
FR2602141B1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
MX9203543A (es) Medicamento.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
FR2613617B1 (fr) Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
PT83556B (de) Biologisch aktive derivate des human-gama-interferons ihre herstellung und arzneimittel die solche derivate enthalten
KR890701094A (ko) 활성성분의 피부조직 전이흡수를 보장하는 약제학적 제제형 및 그 조제방법
FR2600891B1 (fr) Produit pharmaceutique pour la stimulation de l'apprentissage et l'amelioration de la memoire contenant comme principe actif, le chlorhydrate de 9-amino-2,3, 5,6,7,8,-hexahydro-14-cyclopenta(b)quinoline monohydrate
GR3032224T3 (en) Therapeutic agent for threatened abortion.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
RU96122561A (ru) Способ комплексной терапии заболеваний
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
FR2607719B1 (fr) Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant
DK644487A (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
IT1224897B (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
EP0178176A3 (en) Tetrahydro-1,2,4-oxadiazine-5-thione derivatives

Legal Events

Date Code Title Description
ST Notification of lapse